NEOGMID

Neogen Corporation

HealthcareMedical - Diagnostics & Research
$9.51
$0.00(+1.82%)
52W$4.56
$11.43
Updated Jul 7, 02:00 AM
RSI53
RS Rating67/99
Beta1.45
Volatility59%
F-Score3/9
Mkt Cap$2.1B
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

Neogen Corporation is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is moderate (RS Rating: 67), indicating performance broadly in line with the market. Earnings contraction of 58% provides fundamental context to the price action. Investors should exercise caution due to high volatility (59% annualized), which requires wider risk management.

Relative Strength
67
out of 99
Average
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
1.45
vs S&P 500
ABOVE MKT
52W Position
72%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$9.07
50 SMA > 100 SMA$9.49
100 SMA > 150 SMA$9.05
150 SMA > 200 SMA$8.28

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$9.19+3.43%ABOVE
50 SMA$9.07+4.82%ABOVE
100 SMA$9.49+0.16%ABOVE
150 SMA$9.05+5.04%ABOVE
200 SMA$8.28+14.86%ABOVE

Price Performance

1D+1.8%
1W+4.5%
1M+4.9%
3M-0.5%
6M+28.3%
YTD+35.9%
1Y+91.0%
3Y-23.5%
52-Week Trading Range72% from low
$9.51
52W Low$4.56
52W High$11.43

Technical Indicators

RSI (14)NEUTRAL
53.4
305070
Setup ScoreCOOL
3/10
Base depth: 28.1%

Risk Profile

Beta
1.45
52W Vol
59%
ATR
$0.41
Max DD (1Y)
-28%

Volume Analysis

Today
1.60M
50D Avg
1.96M
Vol Ratio
0.82x
Liquidity
MODERATE

Earnings Momentum

Q4'25-11180%
$-2.82
Q1'26+392%
$0.17
Q2'26+97%
$-0.07
Q3'26-58%
$-0.08
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+12.20%
5 Years:+16.43%
3 Years:+19.28%
TTM:-3.91%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-25.50%

Stock Price CAGR

10 Years:-7.83%
5 Years:-26.96%
3 Years:-23.47%
1 Year:+90.96%

Return on Equity

10Y Avg:2.1%
5Y Avg:-6.0%
3Y Avg:-14.4%
Last Year:-29.0%

Key Metrics

Market Cap$2.1B
Gross Margin47.1%
Net Margin-1.2%
Piotroski F-Score3/9

Frequently Asked Questions

Is NEOG in an uptrend right now?

NEOG has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is NEOG overbought or oversold?

NEOG's RSI (14) is 53. The stock is in neutral territory, neither overbought nor oversold.

Is NEOG outperforming the market?

NEOG has a Relative Strength (RS) Rating of 67 out of 99. NEOG is performing about average compared to the market.

Where is NEOG in its 52-week range?

NEOG is trading at $9.51, which is 83% of its 52-week high ($11.43) and 72% above its 52-week low ($4.56).

How volatile is NEOG?

NEOG has a Beta of 1.45 and 52-week volatility of 59%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.